Join KBI Biopharma at the WCBP Symposium 2024! Be sure to stop by Booth #4 to chat with our team of experts. We look forward to seeing you in Washington DC!
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
The WCBP Symposium has established a reputation as the highest-regarded annual conference addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. This year, WCBP 2024 will be co-sponsored by the US FDA. The regulatory expertise unique to the FDA is essential to the effective communication of such technology and its applications.